Saudi Arabia Healthcare Market: Vision 2030, privatisation and outlook 2026–2032

Saudi Arabia is the largest healthcare market in the GCC and one of the largest reform programmes in healthcare anywhere. Under Vision 2030’s Health Sector Transformation Program, public hospitals are being corporatised into regional health clusters, the Ministry of Health is becoming a regulator and payer rather than an operator, private and PPP provision is expanding, and NUPCO centralises purchasing for the public sector. Published estimates for 2025 range from USD 76.8 bn to USD 76.8 bn; our central estimate is USD 72.0 bn, growing at about 6% to USD 108 bn by 2032.

Demand is driven by a young but rapidly ageing population, very high chronic-disease prevalence, expanding insurance coverage (CCHI mandatory private insurance for expatriates and a growing share of nationals), and giga-projects with their own health infrastructure. Supply-side, the state is investing in localisation — pharmaceutical and device manufacturing, and a national health workforce — which changes how suppliers must position themselves.

The chart shows the Consulting Wallah central estimate: published figures normalised to 2025, median taken, and projected at the median published growth rate. The published range for 2025 is USD 76.8 bn–USD 76.8 bn; differences are mostly scope.

Included: public and private hospital, clinic, diagnostic and long-term care services and the associated health expenditure. Excluded: pharmaceutical and device product markets, insurance premiums and health IT (separate reports). Institutions: Ministry of Health, Health Holding Company (PIF), health clusters, CCHI/Council of Health Insurance, NUPCO, SFDA, Saudi Health Council.

Shares as reported by the named sources; ranking is more reliable than the exact percentage.

• Saudi Arabia accounts for ~60% of GCC healthcare expenditure; government spending >60% of national healthcare expenditure (trade.gov)
• 499 hospitals and 80,072 beds in 2023; MoH 59%, quasi-government 18%, private 23% of beds (KTrade)
• HMG 2024 revenue SAR 11.2 bn (18% CAGR 2020-24), 2,888 beds, 74% of revenue from insurance (KTrade)
• Seha Virtual Hospital remotely supports 130 hospitals; Sehhaty digital platform has 31m users (trade.gov; PharmaKnowl)
• NUPCO bids require NUPCO prequalification and SFDA product registration (trade.gov)
• 84,000 new hospital beds needed by 2030 (TASC); Alpen Capital puts Saudi additions at >8,500 beds 2024-2029 (TASC; Alpen Capital)
• HMG IPO (March 2020) was ~83x oversubscribed with orders near SAR 217 bn; HMG market value ~USD 21.9 bn (Zavis / Argaam)
• Mouwasat holds ~31% of private beds in the Eastern Province; Dallah's 83% of revenue is from insurance (KTrade)
• Saudi digital health market USD 2.5 bn (2024) to USD 16.94 bn (2033) per Research and Markets (BusinessWire)

Structure

Twenty-plus health clusters now run public hospitals as corporatised entities under the Health Holding Company; model-of-care reform pushes volume to primary care and virtual care (Seha Virtual Hospital). PPPs cover hospitals, dialysis, radiology, laboratories and logistics. NUPCO handles framework tendering, warehousing and distribution for public entities; private groups buy independently.

Private sector

Dr Sulaiman Al Habib, Mouwasat, Dallah, Fakeeh Care, Al Hammadi, Saudi German, Bupa Arabia and Tawuniya (payers) are listed; expansion is concentrated in Riyadh, Jeddah, the Eastern Province and now secondary cities.

India link

India supplies a large share of Saudi pharmaceutical imports, nursing and clinical workforce, and is a growing source of devices and consumables; Saudi localisation policies favour suppliers willing to manufacture or partner locally.

Key companies named across the sources; local distributors and implementation partners matter as much as the brand in the GCC and India.

• Suppliers: SFDA registration, a licensed local agent, NUPCO prequalification and increasingly a localisation plan are the gates; frameworks are large and multi-year — losing one tender means waiting years.
• Operators and investors: PPP and cluster outsourcing (dialysis, imaging, labs, long-term care, home care) are the entry points; secondary-city private hospitals are the capacity gap.
• Hospital leaders: cluster budgets and insurer tariffs are tightening; procurement benchmarking across clusters is the quickest saving.

1. US International Trade Administration, Saudi Arabia Country Commercial Guide - Healthcare — trade.gov
2. KTrade (KASB), Healthcare Chartbook May 2025 — kasb.com
3. Research and Markets via GlobeNewswire, Saudi Arabia $25+ Bn Hospital Market 2030F — globenewswire.com
4. Markntel Advisors, Saudi Arabia Healthcare Market 2026-2032 — marknteladvisors.com
5. TASC Outsourcing, Saudi Healthcare Industry report — tascoutsourcing.com
6. Argaam, Saudi firms unveil healthcare investments at Global Health Exhibition — argaam.com
7. BCC Research, Healthcare Innovation in the GCC — bccresearch.com
8. Zavis / Dealroom, Saudi appoints HMG IPO chief to lead Health Holding Company — zavis.ai
9. Zawya / Saudi Gazette, Ministry launches health clusters across Saudi Arabia — zawya.com
10. PharmaKnowl, MedTech industry statistics in the Gulf markets — pharmaknowl.com
11. US ITA Country Commercial Guide (trade.gov) (2026-05) — USD 61 bn (public USD 45 bn + private USD 16 bn) (2022) to USD 102 bn (public USD 69 bn + private USD 33 bn) (2035), CAGR —; scope: Total national healthcare expenditure; Saudi ~60% of GCC healthcare spend; government >60% of spend — source
12. Consulting Wallah Network — anonymised observations from procurement and business-setup work with hospital groups and suppliers in the UAE, India and Bangladesh (2024–26), used for the GCC/India outlook and the “what it means” section.
13. Method. Each published figure is normalised to a 2025 base using its own CAGR; the Consulting Wallah central estimate is the median of the normalised figures (or the stated scope where noted) projected at the median CAGR to 2032. Country figures are quoted as published; where we add a CW estimate it is labelled.